D.E. Shaw & Co’s iShares Biotechnology ETF IBB Stock Holding History

D.E. Shaw & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1M	Sell	68,971 -320,085	-82%	-$55M	0.01%	1608
2026 Q1	$65.7M	Buy	389,056 +349,812	+891%	+$59.8M	0.04%	547
2025 Q4	$6.62M	Buy	+39,244	New	+$6.37M	﹤0.01%	2081
2025 Q2	–	Sell	-54,801	Closed	-$7.01M	–	4498
2025 Q1	$7.01M	Buy	+54,801	New	+$7.43M	0.01%	1655
2024 Q4	–	Sell	-45,232	Closed	-$6.59M	–	4589
2024 Q3	$6.59M	Buy	45,232 +28,087	+164%	+$4.06M	0.01%	1737
2024 Q2	$2.35M	Sell	17,145 -58,024	-77%	-$7.75M	﹤0.01%	2515
2024 Q1	$10.3M	Buy	+75,169	New	+$10.3M	0.01%	1338
2020 Q2	–	Sell	-38,250	Closed	-$4.12M	–	4099
2020 Q1	$4.12M	Hold	38,250	–	–	0.01%	1608
2019 Q4	$4.61M	Buy	+38,250	New	+$4.27M	0.01%	1799
2018 Q2	–	Sell	-60,000	Closed	-$6.4M	–	3776
2018 Q1	$6.4M	Buy	+60,000	New	+$6.65M	0.01%	1258
2017 Q1	–	Sell	-24,000	Closed	-$2.12M	–	3427
2016 Q4	$2.12M	Buy	+24,000	New	+$2.18M	﹤0.01%	1949
2016 Q3	–	Sell	-19,167	Closed	-$1.64M	–	3437
2016 Q2	$1.64M	Sell	19,167 -136,533	-88%	-$12.3M	﹤0.01%	2073
2016 Q1	$13.5M	Sell	155,700 -15,933	-9%	-$1.42M	0.02%	698
2015 Q4	$19.4M	Buy	+171,633	New	+$18.6M	0.03%	650
2015 Q3	–	Sell	-65,400	Closed	-$8.04M	–	3795
2015 Q2	$8.04M	Buy	+65,400	New	+$7.83M	0.01%	1150

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

D.E. Shaw & Co's IBB Position: Q2 2026 in Review

D.E. Shaw & Co reduced its iShares Biotechnology ETF (IBB) stake by 82% in Q2 2026, selling an estimated $55M and leaving 68,971 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #1608.

D.E. Shaw & Co first reported a position in IBB in Q2 2015 and has held it in 15 quarters since. The position peaked at $65.7M in Q1 2026. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

D.E. Shaw & Co held 68,971 shares of iShares Biotechnology ETF worth $13.1M as of Q2 2026.
D.E. Shaw & Co sold 320,085 iShares Biotechnology ETF shares in Q2 2026, an estimated $55M.
iShares Biotechnology ETF made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1608 holding.
D.E. Shaw & Co first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 15 quarters since.
D.E. Shaw & Co's iShares Biotechnology ETF position peaked at $65.7M in Q1 2026.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.